Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1982 Jan;45(1):55–59. doi: 10.1136/jnnp.45.1.55

A comparison of phenytoin and valproate in previously untreated adult epileptic patients.

D M Turnbull, M D Rawlins, D Weightman, D W Chadwick
PMCID: PMC491265  PMID: 6801213

Abstract

Eighty-eight patients with the onset of epilepsy in adult life were randomly allocated to treatment with sodium valproate (600 mg/day), or phenytoin (300 mg/day), and followed up for at least 12 months. Both drugs were highly effective in the control of tonic-clonic seizures, irrespective of whether they were accompanied by focal features, but were markedly less effective in the control of partial seizures. Two patients exhibited acute allergic reactions to phenytoin. No significant differences have yet emerged in the efficacy of the two drugs, and valproate may be considered as a "fist-line" anticonvulsant in the treatment of adult onset epilepsy.

Full text

PDF
55

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chadwick D. W., Cumming W. J., Livingstone I., Cartlidge N. E. Acute intoxication with sodium valproate. Ann Neurol. 1979 Dec;6(6):552–553. doi: 10.1002/ana.410060616. [DOI] [PubMed] [Google Scholar]
  2. Coulter D. L., Wu H., Allen R. J. Valproic acid therapy in childhood epilepsy. JAMA. 1980 Aug 22;244(8):785–788. [PubMed] [Google Scholar]
  3. Hassan M. N., Laljee H. C., Parsonage M. J. Sodium valproate in the treatment of resistant epilepsy. Acta Neurol Scand. 1976 Sep;54(3):209–218. doi: 10.1111/j.1600-0404.1976.tb04797.x. [DOI] [PubMed] [Google Scholar]
  4. Hyman N. M., Dennis P. D., Sinclair K. G. Tremor due to sodium valproate. Neurology. 1979 Aug;29(8):1177–1180. doi: 10.1212/wnl.29.8.1177. [DOI] [PubMed] [Google Scholar]
  5. Jeavons P. M., Clark J. E., Maheshwari M. C. Treatment of generalized epilepsies of childhood and adolescence with sodium valproate ("epilim"). Dev Med Child Neurol. 1977 Feb;19(1):9–25. doi: 10.1111/j.1469-8749.1977.tb08015.x. [DOI] [PubMed] [Google Scholar]
  6. Pinder R. M., Brogden R. N., Speight T. M., Avery G. S. Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs. 1977 Feb;13(2):81–123. doi: 10.2165/00003495-197713020-00001. [DOI] [PubMed] [Google Scholar]
  7. Reynolds E. H., Chadwick D., Galbraith A. W. One drug (phenytoin) in the treatment of epilepsy. Lancet. 1976 May 1;1(7966):923–926. doi: 10.1016/s0140-6736(76)92709-4. [DOI] [PubMed] [Google Scholar]
  8. Reynolds E. H. Chronic antiepileptic toxicity: a review. Epilepsia. 1975 Jun;16(2):319–352. doi: 10.1111/j.1528-1157.1975.tb06062.x. [DOI] [PubMed] [Google Scholar]
  9. Reynolds E. H., Shorvon S. D. Monotherapy or polytherapy for epilepsy? Epilepsia. 1981 Feb;22(1):1–10. doi: 10.1111/j.1528-1157.1981.tb04327.x. [DOI] [PubMed] [Google Scholar]
  10. Shakir R. A., Johnson R. H., Lambie D. G., Melville I. D., Nanda R. N. Comparison of sodium valproate and phenytoin as single drug treatment in epilepsy. Epilepsia. 1981 Feb;22(1):27–33. doi: 10.1111/j.1528-1157.1981.tb04330.x. [DOI] [PubMed] [Google Scholar]
  11. Shorvon S. D., Chadwick D., Galbraith A. W., Reynolds E. H. One drug for epilepsy. Br Med J. 1978 Feb 25;1(6111):474–476. doi: 10.1136/bmj.1.6111.474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Simon D., Penry J. K. Sodium di-N-propylacetate (DPA) in the treatment of epilepsy. A review. Epilepsia. 1975 Nov;16(4):549–573. doi: 10.1111/j.1528-1157.1975.tb04738.x. [DOI] [PubMed] [Google Scholar]
  13. Ware S., Millward-Sadler G. H. Acute liver disease associated with sodium valproate. Lancet. 1980 Nov 22;2(8204):1110–1113. doi: 10.1016/s0140-6736(80)92543-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES